Pieter‐Jan de Kam

1.2k total citations
47 papers, 831 citations indexed

About

Pieter‐Jan de Kam is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Allergy and Surgery. According to data from OpenAlex, Pieter‐Jan de Kam has authored 47 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 14 papers in Immunology and Allergy and 12 papers in Surgery. Recurrent topics in Pieter‐Jan de Kam's work include Allergic Rhinitis and Sensitization (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Anesthesia and Sedative Agents (9 papers). Pieter‐Jan de Kam is often cited by papers focused on Allergic Rhinitis and Sensitization (10 papers), Atrial Fibrillation Management and Outcomes (9 papers) and Anesthesia and Sedative Agents (9 papers). Pieter‐Jan de Kam collaborates with scholars based in Netherlands, United States and United Kingdom. Pieter‐Jan de Kam's co-authors include Pierre Peeters, P. A. M. Peeters, Guy Cammu, L. Foubert, Marita Prohn, A.T. Marcel Gosselink, Jean Smeets, T. Thomsen, Peter Grobara and K.I. Lie and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Allergy and Clinical Immunology.

In The Last Decade

Pieter‐Jan de Kam

40 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pieter‐Jan de Kam Netherlands 18 320 285 229 133 105 47 831
Constance Barazzone Argiroffo Switzerland 13 63 0.2× 176 0.6× 121 0.5× 39 0.3× 6 0.1× 23 727
Adam Chahine United States 15 173 0.5× 35 0.1× 98 0.4× 19 0.1× 3 0.0× 28 545
Takeshi Motomiya Japan 15 255 0.8× 27 0.1× 133 0.6× 12 0.1× 7 0.1× 69 584
Bryan Voss United States 11 106 0.3× 60 0.2× 106 0.5× 3 0.0× 23 0.2× 14 577
M Takaori Japan 13 50 0.2× 75 0.3× 111 0.5× 43 0.3× 59 530
Armando Soldarini Italy 10 53 0.2× 34 0.1× 119 0.5× 8 0.1× 8 0.1× 17 560
Sjoerd van Marle Netherlands 10 60 0.2× 42 0.1× 70 0.3× 16 0.1× 3 0.0× 19 481
J.J. Thebault France 11 211 0.7× 8 0.0× 123 0.5× 18 0.1× 26 0.2× 22 542
Rahim Behnia United States 10 139 0.4× 31 0.1× 133 0.6× 8 0.1× 2 0.0× 32 427

Countries citing papers authored by Pieter‐Jan de Kam

Since Specialization
Citations

This map shows the geographic impact of Pieter‐Jan de Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pieter‐Jan de Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pieter‐Jan de Kam more than expected).

Fields of papers citing papers by Pieter‐Jan de Kam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pieter‐Jan de Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pieter‐Jan de Kam. The network helps show where Pieter‐Jan de Kam may publish in the future.

Co-authorship network of co-authors of Pieter‐Jan de Kam

This figure shows the co-authorship network connecting the top 25 collaborators of Pieter‐Jan de Kam. A scholar is included among the top collaborators of Pieter‐Jan de Kam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pieter‐Jan de Kam. Pieter‐Jan de Kam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zielen, Stefan, Jonathan A. Bernstein, Gunter J. Sturm, et al.. (2025). Six Injections of Modified Adjuvanted PQ Grass Is Effective and Well‐Tolerated in a Pivotal Phase III Trial. Allergy. 80(7). 1982–1994. 2 indexed citations
2.
3.
Pfaar, Oliver, Ralph Mösges, Michael S. Blaiss, et al.. (2025). The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach. Allergy. 80(12). 3369–3376.
4.
Layhadi, Janice A., Pieter‐Jan de Kam, Elizabeth Palmer, et al.. (2025). Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals. Journal of Allergy and Clinical Immunology. 155(1). 153–165. 2 indexed citations
5.
Kam, Pieter‐Jan de, Matthias Krämer, Mohamed H. Shamji, et al.. (2021). Dogmas, challenges, and promises in phase III allergen immunotherapy studies. World Allergy Organization Journal. 14(9). 100578–100578. 5 indexed citations
6.
Heath, Matthew D., Mona O. Mohsen, Pieter‐Jan de Kam, et al.. (2020). Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®). Frontiers in Immunology. 11. 594911–594911. 18 indexed citations
7.
Zielen, Stefan, Piotr Kuna, Werner Aberer, et al.. (2019). Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing. World Allergy Organization Journal. 12(11). 100075–100075. 13 indexed citations
8.
Pfaar, Oliver, Claus Bachert, Piotr Kuna, et al.. (2018). Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma. Journal of Allergy and Clinical Immunology. 143(3). 970–977. 31 indexed citations
9.
Kam, Pieter‐Jan de, Hendrik Nolte, Susan P. Good, et al.. (2018). Sugammadex hypersensitivity and underlying mechanisms: a randomised study of healthy non-anaesthetised volunteers. British Journal of Anaesthesia. 121(4). 758–767. 39 indexed citations
10.
Kruithof, Annelieke C., Matthijs Moerland, Eleftheria A. Anastasopoulou, et al.. (2015). Evaluation of the Effect of Aspirin on Platelet Aggregation: Methodological Recommendations for Aspirin-Drug Interaction Studies. Journal of Biomedical Science and Engineering. 8(1). 40–45.
11.
Kam, Pieter‐Jan de, et al.. (2015). Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers. International Journal of Clinical Pharmacology and Therapeutics. 53(6). 456–461. 7 indexed citations
12.
Kam, Pieter‐Jan de, Annelieke C. Kruithof, Jacobus Burggraaf, et al.. (2015). A PK-PD model-based assessment of sugammadex effects on coagulation parameters. European Journal of Pharmaceutical Sciences. 84. 9–17. 3 indexed citations
13.
Kam, Pieter‐Jan de, Martijn P. van den Heuvel, Peter Grobara, et al.. (2011). Flucloxacillin and Diclofenac do not Cause Recurrence of Neuromuscular Blockade after Reversal with Sugammadex. Clinical Drug Investigation. 32(3). 203–212. 9 indexed citations
14.
Cammu, Guy, Pieter‐Jan de Kam, Ignace Demeyer, et al.. (2008). Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. British Journal of Anaesthesia. 100(3). 373–379. 77 indexed citations
15.
Kam, Pieter‐Jan de, et al.. (2008). Single IV sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium are not associated with QTc prolongation. European Journal of Anaesthesiology. 25(Sup 44). 137–138. 9 indexed citations
16.
Kam, Pieter‐Jan de, Adriaan A. Voors, Jan Brouwer, Martin St. John Sutton, & Wiek H. van Gilst. (2002). Approaches to Statistical Analysis of Repeated Echocardiographic Measurements After Myocardial Infarction and its Relation to Heart Failure: Application of a Random-Effects Model. European Journal of Heart Failure. 4(3). 277–282.
17.
Libourel, Eduard J., et al.. (2002). Protein C/S ratio, an accurate and simple tool to identify carriers of a protein C gene mutation. British Journal of Haematology. 118(2). 615–618. 1 indexed citations
18.
Lefrandt, J. D., J. Heitmann, Knut Sevre, et al.. (2001). Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension. British Journal of Clinical Pharmacology. 52(6). 687–692. 5 indexed citations
19.
Meinardi, Johan R., Saskia Middeldorp, Pieter‐Jan de Kam, et al.. (2001). Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. Blood Coagulation & Fibrinolysis. 12(8). 713–720. 22 indexed citations
20.
Meinardi, Johan R., C M A Henkens, Pieter‐Jan de Kam, & Jan van der Meer. (1999). State-of-the-Art Review : Acquired APC Resistance in Neurosurgical Patients May Not Be a Risk Factor for Postoperative Deep Vein Thrombosis. Clinical and Applied Thrombosis/Hemostasis. 5(2). 105–109.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Constance Barazzone Argiroffo Breakdown of academic impact, for papers by Adam Chahine Breakdown of academic impact, for papers by Takeshi Motomiya Breakdown of academic impact, for papers by Bryan Voss Breakdown of academic impact, for papers by M Takaori Breakdown of academic impact, for papers by Armando Soldarini Breakdown of academic impact, for papers by Sjoerd van Marle Breakdown of academic impact, for papers by J.J. Thebault Breakdown of academic impact, for papers by Rahim Behnia
Rankless by CCL
2026